Analysts: AMAG Pharmaceuticals Inc (AMAG.OQ)
AMAG.OQ on NASDAQ Stock Exchange Global Select Market
23.61USD
1 Aug 2013
23.61USD
1 Aug 2013
Price Change (% chg)
$1.11 (+4.93%)
$1.11 (+4.93%)
Prev Close
$22.50
$22.50
Open
$23.15
$23.15
Day's High
$23.72
$23.72
Day's Low
$22.92
$22.92
Volume
22,309
22,309
Avg. Vol
36,596
36,596
52-wk High
$25.63
$25.63
52-wk Low
$13.90
$13.90
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Outperform | -0.18 | December | 2 Aug 2013 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 3 | 3 | 3 | 3 |
| (2) OUTPERFORM | 0 | 0 | 0 | 0 |
| (3) HOLD | 3 | 3 | 3 | 3 |
| (4) UNDERPERFORM | 0 | 0 | 0 | 0 |
| (5) SELL | 1 | 1 | 1 | 1 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 2.43 | 2.43 | 2.43 | 2.43 |
Consensus Estimates Analysis
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-13 | 6 | 19.34 | 21.10 | 17.64 | -- |
| Quarter Ending Dec-13 | 6 | 19.95 | 21.08 | 18.93 | -- |
| Year Ending Dec-13 | 7 | 75.65 | 80.17 | 71.99 | 79.78 |
| Year Ending Dec-14 | 6 | 93.40 | 102.03 | 81.81 | 94.70 |
| Earnings (per share) | |||||
| Quarter Ending Sep-13 | 6 | -0.18 | -0.10 | -0.27 | -- |
| Quarter Ending Dec-13 | 6 | -0.16 | -0.10 | -0.23 | -- |
| Year Ending Dec-13 | 7 | -0.67 | -0.51 | -0.91 | -0.71 |
| Year Ending Dec-14 | 6 | -0.08 | 0.18 | -0.23 | -0.06 |
Historical Surprises
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Mar-13 | 17.90 | 17.88 | 0.02 | 0.09 |
| Quarter Ending Dec-12 | 22.54 | 21.14 | 1.40 | 6.21 |
| Quarter Ending Sep-12 | 20.43 | 17.74 | 2.69 | 13.17 |
| Quarter Ending Jun-12 | 21.29 | 31.01 | 9.72 | 45.66 |
| Quarter Ending Mar-12 | 14.92 | 15.48 | 0.56 | 3.74 |
| Earnings (per share) | ||||
| Quarter Ending Mar-13 | -0.21 | -0.19 | 0.02 | -10.25 |
| Quarter Ending Dec-12 | -0.06 | -0.17 | 0.11 | -161.54 |
| Quarter Ending Sep-12 | -0.26 | -0.19 | 0.07 | -27.73 |
| Quarter Ending Jun-12 | -0.31 | 0.14 | 0.45 | -145.80 |
| Quarter Ending Mar-12 | -0.63 | -0.58 | 0.05 | -8.56 |
Consensus Estimates Trend
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-13 | 19.34 | 19.34 | 19.34 | 19.24 | -- |
| Quarter Ending Dec-13 | 19.95 | 19.95 | 19.95 | 19.82 | -- |
| Year Ending Dec-13 | 75.65 | 75.65 | 75.65 | 76.17 | 79.78 |
| Year Ending Dec-14 | 93.40 | 93.40 | 93.40 | 93.40 | 94.70 |
| Earnings (per share) | |||||
| Quarter Ending Sep-13 | -0.18 | -0.18 | -0.18 | -0.18 | -- |
| Quarter Ending Dec-13 | -0.16 | -0.16 | -0.16 | -0.16 | -- |
| Quarter Ending Dec-13 | -0.67 | -0.67 | -0.67 | -0.63 | -0.71 |
| Quarter Ending Dec-14 | -0.08 | -0.08 | -0.08 | -0.08 | -0.06 |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Quarter Ending Sep-13 | 0 | 0 | 0 | 0 |
| Quarter Ending Dec-13 | 0 | 0 | 0 | 0 |
| Year Ending Dec-13 | 0 | 0 | 0 | 0 |
| Year Ending Dec-14 | 0 | 0 | 0 | 0 |
| Earnings | ||||
| Quarter Ending Sep-13 | 0 | 0 | 0 | 0 |
| Quarter Ending Dec-13 | 0 | 0 | 0 | 0 |
| Year Ending Dec-13 | 0 | 0 | 0 | 0 |
| Year Ending Dec-14 | 0 | 0 | 0 | 0 |
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: ValuEngine, Inc.
|
$25.00
|
|
Provider: Wright Reports
|
$472.00
|
|
Provider: S&P Capital IQ Quantitative Report
|
$69.00
|
|
Provider: Pechala's Reports
|
$15.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Earnings vs.
Estimates